U.S. Energy Services Stock News

BioMarin Pharmaceutical (BMRN) stock is back in focus after the FDA accepted the company’s supplemental New Drug Application for VOXZOGO, a key regulatory step toward potential full approval in achondroplasia. See our latest analysis for BioMarin Pharmaceutical. At a share price of US$58.87, BioMarin Pharmaceutical has seen a 10.7% 90 day share price return, while the 1 year total shareholder return has declined 1.5%, suggesting recent momentum contrasts with weaker longer term results. If...

In the past quarter, Vicor Corporation reported second-quarter 2026 revenue of US$143.35 million and net income of US$49.77 million, with both basic and diluted earnings per share from continuing operations rising year-on-year and first-half 2026 results also showing higher revenue and earnings versus the prior year. Beyond the headline figures, Vicor’s results were supported by strong demand for advanced power products tied to AI infrastructure, growing licensing income, and management’s...

First Citizens BancShares, Inc. reported past second-quarter 2026 results showing net interest income of US$1,656 million and net income of US$672 million, with basic and diluted EPS from continuing operations of US$55.52, alongside affirming a quarterly dividend of US$2.10 per share payable in September 2026. Alongside higher earnings, the company completed a large US$2.69 billion buyback program that retired 11.23% of its shares, signaling strong capital flexibility and management...

SiTime’s share price has delivered very strong gains over the past three years, yet the valuation checks now lean expensive, which raises the question of how much optimism is already reflected in the current US$576.41 level. The stock has returned 376.1% over three years, which puts extra focus on whether the current price already embeds a lot of the expected growth story. The recently completed acquisition of Renesas' timing business can support growth expectations in precision timing and...

Intel (NasdaqGS:INTC) has signed a non binding memorandum of understanding with Lens Technology focused on advanced TGV packaging. The agreement targets collaboration across AI PC hardware, data center platforms, and edge robotics devices. The arrangement signals potential cross border cooperation in precision manufacturing for next generation semiconductor packaging. Intel enters this announcement with its shares at $100.23 and very large 1 year and multi year returns, including a 196.0%...

Stifel Financial (SF) is back in focus after reporting Q2 2026 results and updating investors on its long running share repurchase program, giving shareholders fresh numbers on profitability and capital returns. See our latest analysis for Stifel Financial. Stifel Financial's recent earnings surprise and long running buyback program come after a mixed share price stretch, with a 1 month share price return of 8.16% contrasting with a year to date decline of 6.99%, while the 3 year total...

Earlier this week, Neurocrine Biosciences announced a series of leadership moves, including appointing Samir Siddhanti as Chief Business Officer and naming three new Senior Vice Presidents across market access, intellectual property, and finance. Together, these appointments signal a concerted push to reinforce commercial execution, protect the company’s neuroscience portfolio, and sharpen capital and business development decisions as it matures into a broader multi-product biopharma...

Encore Capital Group (ECPG) told investors it will redeem all outstanding 4.00% Convertible Senior Notes due 2029, covering $230.0 million in principal, with redemption scheduled for September 24, 2026. See our latest analysis for Encore Capital Group. The recent weakness in Encore Capital Group’s share price, with the stock down 7.25% on a 7 day share price return despite a 53.16% year to date share price return and a 120.87% 1 year total shareholder return, suggests strong longer term...

Nektar Therapeutics recently initiated the first two global registrational Phase 3 trials, ZENITH AD-1 and ZENITH AD-2, for rezpegaldesleukin in patients aged 12 and older with moderate-to-severe atopic dermatitis, following encouraging Phase 2b data and prior FDA Fast Track designations. This move advances a first-in-class T-reg–targeting biologic into pivotal testing across North America, Europe and Asia-Pacific, underscoring Nektar’s ambition to build a broad autoimmune and inflammatory...

Wendy's stock has had a weak stretch over the past few years, yet the current valuation work suggests the shares may now be trading at a discount, with both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings-based multiples pointing in the same direction. Wendy's shareholders have seen the stock decline 60.8% over the past 5 years, which sets expectations low and makes the current pricing especially important to scrutinize. For a consumer-focused restaurant chain, the key...

Zillow Group (ZG) is back in focus after fresh housing data tied the company to two pressure points in the U.S. market: rising asking rents and efforts to ease the housing deficit. See our latest analysis for Zillow Group. Against this backdrop, Zillow Group’s share price has come under pressure, with the stock down 5.71% over the past day and 35.22% over 90 days, while the 1 year total shareholder return has declined 61.78%. This suggests sentiment has weakened despite its role in current...

JPMorgan Chase is among global banks arranging a record $40 billion bridge loan for SoftBank to support its artificial intelligence investments. The financing is tied to SoftBank's broader push into AI, including potential opportunities around an anticipated OpenAI IPO. The transaction ranks as one of Asia's largest loan deals and highlights strong bank appetite for large scale technology related funding. For investors watching NYSE:JPM, this SoftBank deal puts JPMorgan Chase at the center...

Agilysys (AGYS) is drawing attention after recent share price moves, with the stock down 2.1% over the past day but up about 10% over the past month and 42% in the past 3 months. See our latest analysis for Agilysys. At a share price of $95.01, Agilysys has recently given investors a mixed ride, with short term share price weakness over the past week but strong 3 month momentum and a positive 3 year total shareholder return of 33.48%. If Agilysys’s recent swings have you thinking about where...

Earlier this month, Belden Inc. announced that its CloudRail brand has partnered with Tulip to help life sciences and consumer packaged goods manufacturers digitize brownfield operations by securely connecting legacy equipment to modern frontline applications without disrupting production. The collaboration marries Belden’s vendor-agnostic OT data acquisition and contextualization with Tulip’s frontline operations platform, aiming to unlock trapped production data and quickly improve overall...

Axon Enterprise stock sits at an unusual valuation crossroads, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium to the current share price while market based multiples suggest the stock screens as undervalued. Axon Enterprise has returned 170.1% over the past 3 years, which puts more pressure on today’s price to justify expectations built into that run. Expectations for bookings growth, including from areas highlighted in recent brokerage commentary such as...

NETSTREIT Corp. has already reported its second-quarter 2026 results, with sales rising to US$57.82 million and revenue reaching US$61.28 million, alongside net income of US$6.29 million and basic earnings per share from continuing operations of US$0.06. For the first half of 2026, NETSTREIT more than doubled net income to US$11.97 million while also lifting the quarterly dividend to US$0.2250 per share, underscoring a focus on income distribution as cash flows improved. Now we will...

Zoetis (ZTS) is back in focus after launching Portela for cats and Lenivia for dogs in Canada and the EU, extending its osteoarthritis pain portfolio with long acting monoclonal antibody therapies. See our latest analysis for Zoetis. Despite the new Portela and Lenivia launches, Zoetis shares have been under pressure, with the 90 day share price return down 36.19% and the 1 year total shareholder return down 50.27%, pointing to fading momentum as investors reassess growth prospects and...

Earlier this week, Mueller Industries, Inc. reported second-quarter 2026 results showing sales of US$1,427.92 million and net income of US$249.66 million, both higher than a year ago, along with modestly increased basic and diluted earnings per share from continuing operations. For the first half of 2026, the company’s sales rose to US$2,620.93 million and net income to US$488.67 million versus the prior-year period, indicating improved profitability across its operations over six...

SouthState Bank (SSB) just released a busy set of corporate updates, combining its second quarter 2026 earnings report with a higher quarterly dividend, fresh buyback data, and new credit quality figures. See our latest analysis for SouthState Bank. Despite the immediate share price easing 0.92% on the day to $101.25 and a 7 day share price return that is also lower, SouthState Bank still shows positive momentum with a 30 day share price return of 2.46% and a 1 year total shareholder return...

Dover stock has delivered a 40.4% return over the past three years, yet today it trades at about US$197.80 with an intrinsic value estimate from a Discounted Cash Flow (DCF) model suggesting it may be modestly undervalued, while market based multiples point closer to a fair price. That mix leaves investors weighing a high level of recent value checks against a share price that no longer looks obviously cheap after its multi year run. Dover’s 40.4% return over three years shows the stock has...

US Foods Holding has delivered a strong 177.0% return over the past five years, yet its low overall value score suggests the stock may no longer be an obvious bargain at today's price of US$95.58. The 177.0% five year return highlights how much of US Foods Holding's potential may already be reflected in the share price. Expectations for the company to keep converting growth into solid cash generation can support the current valuation, while any pressure on profitability or higher capital...

In recent weeks, Truist Financial reported higher second-quarter 2026 net income of US$1,553 million and completed a US$1.25 billion fixed-to-floating senior notes offering, while also finishing a buyback of 46,544,677 shares for about US$2,333.91 million. The appointment of industry veteran Shimna Sameer to lead Truist Wealth adds leadership focus on technology-enabled wealth growth alongside the company’s updated 2026 revenue guidance. Now we will examine how Sameer’s wealth leadership...

Fifth Third Bancorp stock has delivered a strong 124.0% return over the past three years, yet the valuation checks are split, with an intrinsic value estimate from the Excess Returns model pointing to upside while traditional earnings multiples lean expensive and the overall value score is low. Over three years, a 124.0% share price gain puts Fifth Third Bancorp firmly in the group of regional banks that have already rewarded investors significantly. This raises the bar for any further...

Healthpeak Properties (DOC) has drawn investor attention after its recent share performance, with the stock up about 7% over the past month and roughly 34% in the past 3 months. See our latest analysis for Healthpeak Properties. At a share price of $22.08, Healthpeak Properties has recently seen momentum cool slightly, with the 7 day share price return down 1.12% after a strong 30 day gain of 7.39% and a 90 day share price return of 34.39%, while the 1 year total shareholder return of 25.19%...